Nuveen Asset Management LLC Sells 222,100 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Nuveen Asset Management LLC trimmed its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 47.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 249,820 shares of the company's stock after selling 222,100 shares during the quarter. Nuveen Asset Management LLC owned 0.13% of Aveanna Healthcare worth $1,142,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in AVAH. First Eagle Investment Management LLC purchased a new position in Aveanna Healthcare in the 4th quarter worth $1,992,000. Millennium Management LLC grew its stake in shares of Aveanna Healthcare by 105.0% during the fourth quarter. Millennium Management LLC now owns 400,374 shares of the company's stock valued at $1,830,000 after buying an additional 205,023 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its holdings in shares of Aveanna Healthcare by 50.1% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 533,196 shares of the company's stock worth $2,437,000 after buying an additional 177,856 shares during the period. Swiss National Bank bought a new stake in shares of Aveanna Healthcare in the 4th quarter valued at about $434,000. Finally, Federated Hermes Inc. boosted its holdings in Aveanna Healthcare by 3,047.2% during the 4th quarter. Federated Hermes Inc. now owns 89,665 shares of the company's stock valued at $410,000 after acquiring an additional 86,816 shares during the period. Hedge funds and other institutional investors own 87.96% of the company's stock.

Aveanna Healthcare Price Performance

AVAH remained flat at $5.51 during midday trading on Friday. The company's stock had a trading volume of 543,253 shares, compared to its average volume of 313,996. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.32 and a fifty-two week high of $6.19. The firm has a 50 day moving average price of $5.08 and a two-hundred day moving average price of $4.94. The company has a market cap of $1.07 billion, a PE ratio of -16.21 and a beta of 2.03.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 91,061 shares of Aveanna Healthcare stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $5.84, for a total transaction of $531,796.24. Following the sale, the insider now directly owns 545,330 shares of the company's stock, valued at approximately $3,184,727.20. The trade was a 14.31% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of the company's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $5.36, for a total value of $8,365,352.00. Following the transaction, the insider now owns 29,640,756 shares in the company, valued at $158,874,452.16. This trade represents a 5.00% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,887,612 shares of company stock worth $26,269,057 over the last quarter. 7.80% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

AVAH has been the subject of several recent research reports. UBS Group boosted their price objective on Aveanna Healthcare from $4.50 to $5.00 and gave the company a "sell" rating in a research report on Friday, May 9th. Truist Financial lowered their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a report on Friday, April 11th.

Aveanna Healthcare Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.